Strategic question
Which telemonitoring ventures can credibly connect heart-failure patients with cardiologists and meet our eight enterprise criteria?
How Galen Growth helped
From market signal to decision-ready evidence
In two choreographed Scan and Profile sprints, we applied the HealthTech Alpha Alpha Score and a Venture Fit scoring matrix to evaluate 160 ventures, producing a shortlist of 10 and in-depth profiles of the top 3-5.
Outcomes
Converted a broad market scan into enterprise-grade, GDPR-compliant partnership options ready for final selection.
Decision enabled: Enabled the franchise to move from scouting to partnership selection with a decision-ready top 3-5.
Key results
Our approach
A repeatable path to a defensible decision
Define
Clarify the strategic question, decision owner, market boundaries, and success criteria.
Map
Identify the relevant ventures, markets, competitors, partnerships, and evidence signals.
Assess
Evaluate maturity, traction, clinical relevance, commercial fit, and operational readiness.
Decide
Translate the evidence into a shortlist, benchmark, market view, or portfolio recommendation.
Related work
More digital health case studies
Tracking Competitor Moves to Support Global Franchise Strategy
How should we track competitor activity across obesity, diabetes and cardiovascular disease to support global strategic decisions?
Prioritising Markets and Partners to Accelerate a Women’s Health Roadmap
Which priority markets and venture partners should anchor our future women’s health innovation roadmap, starting with telemedicine?
Benchmarking Global Competitor Partnerships to Prioritise Digital Health Strategy
Where are competitors investing and partnering in Digital Health, and what should that mean for our own portfolio strategy?